Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Completed

Conditions studied: Parkinson's Disease, Dyskinesia

In brief

The purpose of the study is to test whether body-worn wireless motion sensors can measure dyskinesias (involuntary movements caused by medications) in individuals with Parkinson disease (PD) independent of voluntary activity being performed and other PD motor symptoms (e.g. tremor).

Key facts

Study ID

NCT01429207

Run by

Great Lakes NeuroTechnologies Inc.

People needed

15

Starts

2011-08-01

Last updated by the study team

2012-06-29

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of probable or definite idiopathic Parkinson Disease with motor fluctuations that include dyskinesias after taking their usual dose of levodopa/carbidopa

You may not qualify if…

• Antipsychotic medications (including quetiapine and clozapine)
• Coexisting neurologic disease such as stroke or dementia
• Lacking capacity for informed consent
• Residing in a nursing home
• comorbid non-neurologic illnesses that impacts the ability to perform the study tasks
• Implantable defibrillators

Where it is running

• University of Rochester Medical Center — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.